SuspendedACTRN12623000667617
Official study titleEfficacy and safety of two versus three high dose psilocybin-assisted therapy sessions in comparison to a placebo for treatment resistant major depressive disorder (TR-MDD): A double blind, 3-arm Phase 2b randomised controlled trial
Recruitment is currently suspended.
In AustraliaDepressionInterventional studyAges 18–65
- Countries
- Australia
- Sponsor
- Swinburne University of Technology, Hawthorn
RecruitingNCT03320304
About this title
A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat Depression.
Read the official source — NCT03320304Official study titleA Global PRospective, Multi-cEnter, ObServational Post-markeT Study tO Assess shoRt, Mid and Long-term Effectiveness and Efficiency of VNS Therapy® as Adjunctive Therapy in reaL-world patIents With diFficult to Treat dEpression.
Multiple locations, including ViennaDepressionObservational studyAges 18+
- Countries
- United Kingdom, Belgium, Austria, + 1 other
- Sponsor
- LivaNova
RecruitingNCT07227454
What is this study about?This study evaluates the safety and effectiveness of Esketamine for people with depression.
Multiple locations, including BirminghamDepressionMedication studyAges 12–17
- Countries
- United States, Brazil, Hungary, + 4 others
- Sponsor
- Janssen Research & Development, LLC
RecruitingNCT05553353
About this title
Dosing rTMS for Depression Post-SCI
Read the official source — NCT05553353Official study titleEvaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury
In CharlestonDepressionDevice studyAges 18–60
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)